Company intelligence / Profile preview

Beta LifeSci

Fairfield, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Beta Life Science is a biotechnology company specializing in the development and manufacture of high-quality life science research reagents. The company provides a comprehensive portfolio of products, including recombinant proteins, monoclonal and polyclonal antibodies, ELISA kits, and small molecule inhibitors. Their offerings support research across various fields such as oncology, immunology, neuroscience, and infectious diseases. In addition to catalog products, Beta Life Science offers custom services including protein expression, antibody production, and assay development to support global academic and industrial researchers.

Modalities: Recombinant proteinMonoclonal antibodySmall moleculePeptides
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Beta LifeSci.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta LifeSci.

Explore the full profile